INDUSTRY & ECONOMY (The Hindu)
NON-CONVENTIONAL ENERGY PM pushes for ‘green’ energy tags New Delhi, June 27 Amid spiralling crude oil prices, the Prime Minister, Dr Manmohan Singh, on Friday asked the Ministry of New and Renewable Energy to draft schemes and guidelines for the introduction of ‘Renewable Energy ...
Ranbaxy buy may hit generic drugs supply (The Hindu)
Mumbai, June 12 Drug-maker Ranbaxy may have got a revitalising shot through its stake sale to Japanese company Daiichi Sankyo, but the transaction is not without its sceptics in the health advocacy circles.
New regulatory body for recombinant pharma products (The Hindu)
New Delhi/ Mumbai, June 27 Drug companies planning to launch recombinant biologics, DNA vaccines and similar genetically modified (GM) pharma products may come under the lens of the proposed National Biotechnology Regulatory Authority (NBRA).
HOME PAGE (The Hindu)
Govt looking at stronger measures New Delhi, June 20 The Union Finance Minister, Mr P. Chidambaram, on Friday promised to consider “stronger measures” on both the “demand and monetary” side to tame inflation. The rate rose to 11.05 per cent, a ...
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors (Marketwire via Yahoo! Finance)
EyeGate Pharma, a privately held, specialty pharmaceutical company using iontophoresis technology to safely and non-invasively deliver therapeutics into the front and back of the eye to treat serious ocular diseases, today announced the appointment of Praveen Tyle, Ph.D., as a member of its Board of Directors. Dr.
|
